"life science" - search results

Schroder Ventures Life Sciences has appointed three new venture partners for its London and Boston offices.

Equity investment in US venture-backed companies has fallen for the fifth consecutive quarter according to PricewaterhouseCoopers and VentureOne. In Q2 of this year, equity investments fell to $8.2bn compared to $10.4bn in Q1. This represents a 21 per cent decrease.

Life sciences and technology are of strategic importance if Europe is to stay a leading knowledge-based economy. In this document the European Commission discusses the wide range of questions, that need to be addressed in this sector, and the complexity of issues attached to it.

Private equity fund managers invested in some real turkeys at the end of the 1990s – that much has now become apparent. And, now that IPOs have disappeared as a quick exit route, it's easy to dismiss the asset class as a has-been. However, there are still plenty of great opportunities out there, you just need to be smart enough to take advantage of them, says INVESCO's Ray Maxwell.

STAR to close on $457m, WestAM announces fisrt close on fund of funds, half-year loss for 2M Invest, Polaris attracts $900m, Prudential beats mezzanine target…

Biotechnology will transform the production of chemicals according to this article from the McKinsey Quarterly. Despite the substantial risk involved, chemical companies should not give up on biotech just yet.

Robert Badavas has been appointed as the new chief operating officer at IT and life science specialists Atlas Venture.

Sweden's private equity market has undergone a period of strong growth over the past few years – the number of investors and the amount of funds raised have both grown significantly. The Swedish market continues to mature as demonstrated by more early-stage investment and more precise industry focus. EVCA details the trends of the last year in this overview.

FFIO presents an insight into the life sciences sector in Flanders and details some of the major players in pharmaceuticals and biotechnology that are already established in the region.

The biotechnology sector is wading through difficult times, but the medium-term prospects remain bright.